JLM-019

N/A

Report date: 2026/05/06 16:38:52

Base Information

Drug NameJLM-019
Drug Alias NameJLM-019
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionCluster of differentiation 80 modulatorsProgrammed death-ligand 1 blockers
TargetsCluster of differentiation 80Programmed death-ligand 1
Therapy Area/IndicationsSolid tumoursLymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJecho Biopharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJecho Biopharmaceuticals Co LtdJieku (Shanghai) Biomedical Research Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphomaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A